BioCentury
ARTICLE | Company News

Corixa and QLTI collaborate

March 3, 2000 8:00 AM UTC

CRXA will provide QLT (QLTI; TSE:QLT) with exclusive rights to use its immunotherapeutic compounds, which QLTI intends to evaluate in combination with its photodynamic therapy. The collaboration will ...